of diclofenac

PreclinicalSmall molecule

HHospital Universitario San Ignacio

of diclofenac is one of 15 small molecule programs targeting Radius Fracture. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Radius FractureActive, not recruiting

Radius FracturePreclinical

Active, not recruiting

Competition

Competitive Landscape

14 competitors in Radius Fracture

#DrugCompanyPhaseTrials

Medrol

Pfizer

Approved

1 2

Toradol

Roche

Approved

1 3

Decadron

AAspen Global Incorporated

Approved

3 4

Advil

KKenvue Brands

Approved

2 5

Tylenol

KKenvue Brands

Approved

2 6

Celebrex

PPhiladelphia Eye Associates

Approved

1 7

Ketalar

AAultman Health Foundation

Xylocaine

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Rayos

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Radius Fracture1 trial

"Supracondylar Radial Nerve Block Guided by Ultrasound Versus Hematoma Block for Analgesic Management in Closed Reduction of Distal Radius Fractures"

Recruiting·HHospital Universitario San Ignacio·N/A·NCT06857110·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for of diclofenac. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — of diclofenac compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for of diclofenac. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hospital Universitario San Ignacio company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: HHospital Universitario San Ignacio

of diclofenac

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Radius Fracture1 trial

References

Drug Info

Quick Facts

Related News